ES2542615T3 - Sustratos para detección cromogénica y métodos de uso en los ensayos y kits de detección - Google Patents

Sustratos para detección cromogénica y métodos de uso en los ensayos y kits de detección Download PDF

Info

Publication number
ES2542615T3
ES2542615T3 ES11751996.7T ES11751996T ES2542615T3 ES 2542615 T3 ES2542615 T3 ES 2542615T3 ES 11751996 T ES11751996 T ES 11751996T ES 2542615 T3 ES2542615 T3 ES 2542615T3
Authority
ES
Spain
Prior art keywords
detection
assays
substrates
methods
chromogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11751996.7T
Other languages
English (en)
Inventor
Brian Daniel Kelly
Christopher Bieniarz
Hiro Nitta
Fabien Gaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventana Medical Systems Inc
Original Assignee
Ventana Medical Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Medical Systems Inc filed Critical Ventana Medical Systems Inc
Application granted granted Critical
Publication of ES2542615T3 publication Critical patent/ES2542615T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Un compuesto descrito mediante la siguiente fórmula:**Fórmula** incluidas las sales del mismo; e incluidas las dos formas enantioméricas R y S y las mezclas racémicas del mismo; en el que R1 se elige entre el grupo formado por hidrógeno, halógeno, un grupo alquilo y un grupo arilo; y en el que R2 se elige entre el grupo formado por hidrógeno, un grupo alquilo y un grupo arilo.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15

Claims (1)

  1. imagen1
    imagen2
ES11751996.7T 2010-08-16 2011-08-12 Sustratos para detección cromogénica y métodos de uso en los ensayos y kits de detección Active ES2542615T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37408710P 2010-08-16 2010-08-16
US374087P 2010-08-16
PCT/US2011/047613 WO2012024185A1 (en) 2010-08-16 2011-08-12 Substrates for chromogenic detection and methods of use in detection assays and kits

Publications (1)

Publication Number Publication Date
ES2542615T3 true ES2542615T3 (es) 2015-08-07

Family

ID=44545920

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11751996.7T Active ES2542615T3 (es) 2010-08-16 2011-08-12 Sustratos para detección cromogénica y métodos de uso en los ensayos y kits de detección

Country Status (5)

Country Link
US (1) US9127028B2 (es)
EP (1) EP2606055B1 (es)
DK (1) DK2606055T3 (es)
ES (1) ES2542615T3 (es)
WO (1) WO2012024185A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013079606A1 (en) 2011-12-01 2013-06-06 Ventana Medical Systems, Inc. Automated dual stain of mirna and protein targets
DK2798355T3 (en) 2011-12-30 2018-12-03 Ventana Med Syst Inc Automated analysis of circulating tumor cells
EP2904374B1 (en) 2012-10-08 2023-11-29 Ventana Medical Systems, Inc. Methods and kits for clarifying pigmented samples
AU2015220750B2 (en) 2014-02-24 2020-04-16 Ventana Medical Systems, Inc. Quinone methide analog signal amplification
DK3152577T3 (en) 2014-06-06 2018-10-01 Ventana Med Syst Inc SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENITY IN BREAST CANCER AND APPLICATIONS HEFAR
CA2976005A1 (en) 2015-02-06 2016-08-11 Cell Idx, Inc. Antigen-coupled immunoreagents

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2643564C2 (de) 1976-09-28 1984-09-20 Bayer Ag, 5090 Leverkusen Alkoxymethyl- oder alkylthiomethylsubstituierte Pyrazolyl-(thiono) (thiol)-phosphor(phosphon)-säureester, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide und Akarizide
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
JPS61157193A (ja) 1984-12-28 1986-07-16 Victor Co Of Japan Ltd 映像信号再生装置
US4772691A (en) 1985-06-05 1988-09-20 The Medical College Of Wisconsin, Inc. Chemically cleavable nucleotides
US4888278A (en) 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US6280929B1 (en) 1986-01-16 2001-08-28 The Regents Of The University Of California Method of detecting genetic translocations identified with chromosomal abnormalities
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5258507A (en) 1990-11-08 1993-11-02 Amoco Corporation Labeling reagents useful for the chemical attachment of nitrophenyl derivative ligands to DNA probes
US5427932A (en) 1991-04-09 1995-06-27 Reagents Of The University Of California Repeat sequence chromosome specific nucleic acid probes and methods of preparing and using
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
DK0656946T4 (da) 1992-08-21 2010-07-26 Univ Bruxelles Immunoglobuliner uden lette kæder
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US7763421B2 (en) 2000-06-05 2010-07-27 Ventana Medical Systems, Inc. Methods for producing nucleic acid hybridization probes that amplify hybridization signal by promoting network formation
US6942970B2 (en) 2000-09-14 2005-09-13 Zymed Laboratories, Inc. Identifying subjects suitable for topoisomerase II inhibitor treatment
ES2609919T3 (es) 2005-04-28 2017-04-25 Ventana Medical Systems, Inc. Enzimas conjugados con anticuerpos mediante un conector de PEG heterobifuncional
US20060246524A1 (en) 2005-04-28 2006-11-02 Christina Bauer Nanoparticle conjugates
AU2006279794B2 (en) 2005-08-12 2011-04-07 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate HSP90 activity
ES2548518T3 (es) 2005-11-23 2015-10-19 Ventana Medical Systems, Inc. Conjugado molecular
WO2008028156A2 (en) 2006-09-01 2008-03-06 Ventana Medical Systems, Inc. Method for producing nucleic acid probes
CA2858359C (en) 2006-11-01 2018-04-03 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US7812140B2 (en) * 2007-04-04 2010-10-12 Xerox Corporation Colorant compounds
CA2687178C (en) 2007-05-23 2014-02-04 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
CN101594302B (zh) 2009-07-01 2011-08-03 华为技术有限公司 数据出队的方法及装置
US20120070862A1 (en) 2009-12-31 2012-03-22 Ventana Medical Systems, Inc. Methods for producing uniquely distinct nucleic acid tags

Also Published As

Publication number Publication date
US9127028B2 (en) 2015-09-08
US20130115593A1 (en) 2013-05-09
DK2606055T3 (en) 2015-09-07
EP2606055A1 (en) 2013-06-26
WO2012024185A1 (en) 2012-02-23
EP2606055B1 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
ES2542615T3 (es) Sustratos para detección cromogénica y métodos de uso en los ensayos y kits de detección
ES2528026T3 (es) Sales de oxalato de ivabridina cristalino y polimorfos de los mismos
ES2528797T3 (es) Compuestos de aza-benzotiofenilo y métodos de uso
AR114631A1 (es) Métodos e intermedios para preparar compuestos de piridina
ECSP10010415A (es) Compuestos novedosos que son inhibidores de erk
ES2524966T3 (es) Derivados de tieno[3,2-c]piridina como inhibidores de quinasas para uso en el tratamiento del cáncer
ES2525481T3 (es) Derivados espirocíclicos de ácido tetrónico
AR068764A1 (es) N-piperazin amidas y su uso en medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de faah.
AR068479A1 (es) (carboxilalquilenfenil) feniloxamidas, procedimiento para su preparacion y una coomposicion farmaceutica
CR20110135A (es) INHIBIDORES DE cMET
DOP2010000047A (es) Compuestos de pirazol y su uso como inhibidores de raf
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
AR053994A1 (es) Sulfonilpirrolidinas sustituidas procedimiento para su preparacion y su uso como medicamentos
AR047917A1 (es) Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparacion de los mismos, y su empleo en medicamentos
AR070479A1 (es) Derivado heterociclico fusionado y su uso
RU2009101945A (ru) Азосоединение и красительсодержащая поляризационная пленка на его основе
CR20150061A (es) Compuesto de pirazolopirimidinas
GT200500257AA (es) Procedimiento para producir derivados de amina opticamente activos
CR10156A (es) Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
RS54730B1 (sr) Inhibitori beta sekretaze
ES2526902T3 (es) Procesos de producción de inhibidores de la girasa y topoisomerasa IV
CR20140217A (es) Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas ii
ECSP099565A (es) Compuesto de 2-amino pirimidina
EA201100920A1 (ru) Новые гербициды